Thanks, that is actually really good to know. I know that all companies running phase 2 and 3 trials must have an EAP, but wasn’t sure if MSB were still actively approving compassionate use given the product is so close to approval. Glad they still are.
Thanks, that is actually really good to know. I know that all...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
91.5¢ |
Change
0.015(1.67%) |
Mkt cap ! $1.044B | |||
| Open | High | Low | Value | Volume |
| 92.0¢ | 93.5¢ | 89.0¢ | $6.949M | 7.616M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 6000 | 91.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 92.0¢ | 134540 | 9 |
View Market Depth
| Last trade - 16.10pm 25/04/2024 (20 minute delay) ? |
|
|||||
|
Last
90.5¢ |
Change
0.015 ( 0.33 %) |
||||
| Open | High | Low | Volume | ||
| 91.0¢ | 93.5¢ | 89.0¢ | 1824946 | ||
| Last updated 15.59pm 25/04/2024 ? | |||||
| MSB (ASX) Chart |